chr2-108010571-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021815.5(SLC5A7):c.1453G>A(p.Val485Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000049 in 1,613,748 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_021815.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC5A7 | NM_021815.5 | c.1453G>A | p.Val485Ile | missense_variant | 9/9 | ENST00000264047.3 | NP_068587.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC5A7 | ENST00000264047.3 | c.1453G>A | p.Val485Ile | missense_variant | 9/9 | 1 | NM_021815.5 | ENSP00000264047.2 | ||
SLC5A7 | ENST00000409059.5 | c.1453G>A | p.Val485Ile | missense_variant | 9/9 | 1 | ENSP00000387346.1 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000104 AC: 26AN: 250918Hom.: 0 AF XY: 0.000118 AC XY: 16AN XY: 135616
GnomAD4 exome AF: 0.0000452 AC: 66AN: 1461624Hom.: 0 Cov.: 31 AF XY: 0.0000495 AC XY: 36AN XY: 727098
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152124Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74316
ClinVar
Submissions by phenotype
Neuronopathy, distal hereditary motor, type 7A;C4310694:Congenital myasthenic syndrome 20 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 21, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC5A7 protein function. ClinVar contains an entry for this variant (Variation ID: 532813). This variant has not been reported in the literature in individuals affected with SLC5A7-related conditions. This variant is present in population databases (rs754211137, gnomAD 0.08%). This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 485 of the SLC5A7 protein (p.Val485Ile). - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Dec 12, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at